ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2023

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Prosperity Wealth Management, Inc. 30,620$23,8840.02%
Simplify Asset Management Inc. 150,000$117,0000.01%
Baillie Gifford 17,147,409$13,374,9800.01%
CSS LLC/IL 90,702$70,7480.01%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 24,000$200.00%
Main Street Financial Solutions, LLC 31,190$24,3280.00%
Rathbones Group PLC 432,818$337,5980.00%
OPPENHEIMER & CO INC 68,171$53,1730.00%
Citadel Advisors 3,549,559$2,768,6560.00%
Renaissance Technologies 1,027,860$8020.00%
COURIER CAPITAL LLC 12,000$9,3600.00%
China Universal Asset Management Co., Ltd. 5,285$40.00%
Bayesian Capital Management, LP 10,486$8,1790.00%
ProShare Advisors LLC 13,466$10,5030.00%
BlackRock Inc. 1,266,124$987,5770.00%
Citadel Advisors 400$3120.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 166,888$130,1720.00%
Sandy Spring Bank 1,050$8190.00%
TWO SIGMA ADVISERS, LP 64,437$50,2610.00%
Daiwa Securities Group Inc. 469$00.00%
External links

This page lists ADAPTIMMUNE THERAPEUTICS PLC's shareholders in Q3 2023. To view ADAPTIMMUNE THERAPEUTICS PLC's shareholder history, click here.